FI112031B - Biologisesti aktiivisen tuotteen uusi käyttö - Google Patents

Biologisesti aktiivisen tuotteen uusi käyttö Download PDF

Info

Publication number
FI112031B
FI112031B FI20020360A FI20020360A FI112031B FI 112031 B FI112031 B FI 112031B FI 20020360 A FI20020360 A FI 20020360A FI 20020360 A FI20020360 A FI 20020360A FI 112031 B FI112031 B FI 112031B
Authority
FI
Finland
Prior art keywords
pro
product
peptides
casein
minerals
Prior art date
Application number
FI20020360A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20020360A0 (fi
Inventor
Olli Tossavainen
Annika Maeyrae-Maekinen
Riitta Korpela
Mirkka Narva
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI20020360A priority Critical patent/FI112031B/fi
Publication of FI20020360A0 publication Critical patent/FI20020360A0/fi
Priority to RU2004128448/15A priority patent/RU2004128448A/ru
Priority to JP2003569223A priority patent/JP4242293B2/ja
Priority to EP02788013A priority patent/EP1485119A1/en
Priority to AU2002352303A priority patent/AU2002352303A1/en
Priority to PCT/FI2002/001051 priority patent/WO2003070267A1/en
Application granted granted Critical
Publication of FI112031B publication Critical patent/FI112031B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20020360A 2002-02-25 2002-02-25 Biologisesti aktiivisen tuotteen uusi käyttö FI112031B (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20020360A FI112031B (fi) 2002-02-25 2002-02-25 Biologisesti aktiivisen tuotteen uusi käyttö
RU2004128448/15A RU2004128448A (ru) 2002-02-25 2002-12-20 Повышение биодоступности минеральных веществ посредством применения биологически активных пептидов
JP2003569223A JP4242293B2 (ja) 2002-02-25 2002-12-20 骨の強化および骨形成を増加させるための組成物
EP02788013A EP1485119A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
AU2002352303A AU2002352303A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
PCT/FI2002/001051 WO2003070267A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020360 2002-02-25
FI20020360A FI112031B (fi) 2002-02-25 2002-02-25 Biologisesti aktiivisen tuotteen uusi käyttö

Publications (2)

Publication Number Publication Date
FI20020360A0 FI20020360A0 (fi) 2002-02-25
FI112031B true FI112031B (fi) 2003-10-31

Family

ID=8563317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020360A FI112031B (fi) 2002-02-25 2002-02-25 Biologisesti aktiivisen tuotteen uusi käyttö

Country Status (6)

Country Link
EP (1) EP1485119A1 (zh)
JP (1) JP4242293B2 (zh)
AU (1) AU2002352303A1 (zh)
FI (1) FI112031B (zh)
RU (1) RU2004128448A (zh)
WO (1) WO2003070267A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4723501B2 (ja) * 2004-07-05 2011-07-13 カルピス株式会社 ペプチド混合物の製造法、抗高血圧ペプチド含有発酵乳の製造法及び抗高血圧ペプチド製剤の製造法
ATE548445T1 (de) * 2006-02-20 2012-03-15 Gervais Danone Sa Laktose nicht fermentierende lactobacillus helveticus
EP2040732A4 (en) 2006-05-15 2009-08-19 Valio Ltd NEW USE OF THERAPEUTICALLY USEFUL PEPTIDES
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
CN103221531B (zh) * 2010-11-09 2018-03-16 朝日集团控股株式会社 具有高蛋白质水解活性的瑞士乳杆菌

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183858A (en) * 1976-12-17 1979-10-25 Ashmead Hh Polyvalent metal proteinates as food additives
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JP3488722B2 (ja) * 1992-03-04 2004-01-19 カルピス株式会社 カルシウム吸収促進活性剤及びその製造法
JP2782142B2 (ja) 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
KR100221124B1 (ko) * 1996-09-23 1999-10-01 한상기 신규한 카제인 및 그 제조방법
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
AU2001245547A1 (en) * 2000-03-13 2001-09-24 Monsanto Technology Llc Process for producing peptide sequences possessing anti-hypertension activity

Also Published As

Publication number Publication date
EP1485119A1 (en) 2004-12-15
JP2005517424A (ja) 2005-06-16
FI20020360A0 (fi) 2002-02-25
JP4242293B2 (ja) 2009-03-25
AU2002352303A1 (en) 2003-09-09
WO2003070267A1 (en) 2003-08-28
RU2004128448A (ru) 2005-04-20

Similar Documents

Publication Publication Date Title
Rocha-Mendoza et al. Invited review: Acid whey trends and health benefits
Papademas et al. Technological utilization of whey towards sustainable exploitation
FI113741B (fi) Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
Walther et al. Cheese in nutrition and health
FI123201B (fi) Maitopohjainen tuote ja valmistusmenetelmä
MX2007010094A (es) Mezcla de oligosacarido.
EP2380581B1 (en) Muscle-building agent
JP5888701B2 (ja) 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌
AU2010244292B2 (en) Product and process for its preparation
RU2549709C1 (ru) Способ производства сметаны пробиотической
TWI475962B (zh) 大豆胜肽－鈣螯合物之製備方法
WO2011108692A1 (ja) 筋肉萎縮防止剤
CA2704092C (en) Food material for inhibiting osteoclastogenesis
TWI761487B (zh) 用於促進血中胺基酸濃度上升之發酵乳
FI112031B (fi) Biologisesti aktiivisen tuotteen uusi käyttö
Alhaj et al. Milk‐derived bioactive components from fermentation
Renner Nutritional aspects
KR102657370B1 (ko) 대두 단백질 분해능, 아미노산 생성능 개선 효과를 갖는 프로바이오틱스 조성물
Madureira et al. Functional dairy ingredients
M I et al. Utilization of milk protein hydrolysate in functional beverages
Sharma Dairy Beverages
Casarotti et al. Fermented Dairy Beverages in Latin America
EP3037100A1 (en) Muscle-atrophy-preventing agent
FI120267B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidien valmistamiseksi
JP2021010374A (ja) Ｂｄｎｆ産生促進剤

Legal Events

Date Code Title Description
MM Patent lapsed